Literature DB >> 23618779

Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study.

Andrea Coppadoro1, Lorenzo Berra, Asheesh Kumar, Riccardo Pinciroli, Marina Yamada, Ulrich H Schmidt, Edward A Bittner, Masao Kaneki.   

Abstract

PURPOSE: Plasma coenzyme Q10 (CoQ10) levels are lower in patients with septic shock (SS) than in healthy controls (HCs). However, CoQ10 status in critically ill patients without SS is unknown. Here, we investigated CoQ10 concentrations in patients with SS and without SS as compared with HCs.
MATERIALS AND METHODS: We enrolled 36 critically ill patients and 18 HCs. Plasma CoQ10 concentrations were measured, and patients' clinical and demographical data were collected.
RESULTS: Plasma CoQ10 concentrations were lower in critically ill patients (0.50±0.36 μg/mL, P<.001), both in patients with SS (0.37±0.25 μg/mL, P=.002) and patients without SS (0.56±0.39, P=.04), as compared with HCs (0.79±0.19). Coenzyme Q10 levels did not differ between patients with SS and patients without SS (P=.13). In critically ill patients, CoQ10 levels inversely correlated with age (r=-0.40, P=.015) and did not correlate with partial pressure of oxygen in the arterial blood/fraction of inspired oxygen, Simplified Acute Physiology Score II, Systemic Organ Failure Assessment score, or mortality. Lower CoQ10 levels were associated with lower activities of daily living score after discharge (P=.005), independent of age.
CONCLUSIONS: Decreased plasma CoQ10 levels are not specific to patients with SS, but rather observed in a broad range of critically ill patients. In critically ill patients, CoQ10 insufficiency may be associated with various conditions; age may be a risk factor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Critically ill patients; Plasma coenzyme Q10; Sepsis; Septic shock

Mesh:

Substances:

Year:  2013        PMID: 23618779      PMCID: PMC4073588          DOI: 10.1016/j.jcrc.2013.02.009

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  34 in total

1.  Survival in critical illness is associated with early activation of mitochondrial biogenesis.

Authors:  Jane E Carré; Jean-Christophe Orban; Lorenza Re; Karen Felsmann; Wiebke Iffert; Michael Bauer; Hagir B Suliman; Claude A Piantadosi; Terry M Mayhew; Patrick Breen; Martin Stotz; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress.

Authors:  J Lagendijk; J B Ubbink; W J Vermaak
Journal:  J Lipid Res       Date:  1996-01       Impact factor: 5.922

3.  Oxidation of LDL and their subfractions: kinetic aspects and CoQ10 content.

Authors:  R Alleva; M Tomasetti; S Bompadre; G P Littarru
Journal:  Mol Aspects Med       Date:  1997

4.  Coenzyme Q10 and exercise training in chronic heart failure.

Authors:  Romualdo Belardinelli; Andi Muçaj; Francesca Lacalaprice; Maridia Solenghi; Giovanna Seddaiu; Federica Principi; Luca Tiano; Gian Paolo Littarru
Journal:  Eur Heart J       Date:  2006-08-01       Impact factor: 29.983

5.  Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults.

Authors:  Michael V Miles; Paul S Horn; Peter H Tang; John A Morrison; Lili Miles; Ton DeGrauw; Amadeo J Pesce
Journal:  Clin Chim Acta       Date:  2004-09       Impact factor: 3.786

6.  Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study.

Authors:  B Delannoy; B Floccard; F Thiolliere; M Kaaki; M Badet; S Rosselli; C E Ber; A Saez; G Flandreau; Claude Guérin
Journal:  Intensive Care Med       Date:  2009-08-20       Impact factor: 17.440

7.  Association between mitochondrial dysfunction and severity and outcome of septic shock.

Authors:  David Brealey; Michael Brand; Iain Hargreaves; Simon Heales; John Land; Ryszard Smolenski; Nathan A Davies; Chris E Cooper; Mervyn Singer
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

8.  Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

Authors:  P H Langsjoen; S Vadhanavikit; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock.

Authors:  Michael W Donnino; Michael N Cocchi; Justin D Salciccioli; Daniel Kim; Ali B Naini; Catherine Buettner; Praveen Akuthota
Journal:  Crit Care       Date:  2011-08-09       Impact factor: 9.097

10.  Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage.

Authors:  Petra Niklowitz; Anka Sonnenschein; Bernd Janetzky; Werner Andler; Thomas Menke
Journal:  Int J Biol Sci       Date:  2007-04-05       Impact factor: 6.580

View more
  6 in total

1.  Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial.

Authors:  Michael W Donnino; Sharri J Mortensen; Lars W Andersen; Maureen Chase; Katherine M Berg; Julia Balkema; Jeejabai Radhakrishnan; Raúl J Gazmuri; Xiaowen Liu; Michael N Cocchi
Journal:  Crit Care       Date:  2015-07-01       Impact factor: 9.097

2.  Coenzyme Q10 in acute influenza.

Authors:  Maureen Chase; Michael N Cocchi; Xiaowen Liu; Lars W Andersen; Mathias J Holmberg; Michael W Donnino
Journal:  Influenza Other Respir Viruses       Date:  2018-09-30       Impact factor: 4.380

Review 3.  Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.

Authors:  Maria Chiara Proto; Donatella Fiore; Chiara Piscopo; Cristina Pagano; Mario Galgani; Sara Bruzzaniti; Chiara Laezza; Patrizia Gazzerro; Maurizio Bifulco
Journal:  Prog Lipid Res       Date:  2021-04-26       Impact factor: 16.195

4.  Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients.

Authors:  Naohide Kuriyama; Tomoyuki Nakamura; Harumasa Nakazawa; Tyler Wen; Lorenzo Berra; Edward A Bittner; Jeremy Goverman; Masao Kaneki
Journal:  Metabolites       Date:  2022-07-01

5.  Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy.

Authors:  Takashi Kasai; Takahiko Tokuda; Takuma Ohmichi; Ryotaro Ishii; Harutsugu Tatebe; Masanori Nakagawa; Toshiki Mizuno
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

6.  Effect of coenzyme Q10 supplementation on oxidative stress and clinical outcomes in patients with low levels of coenzyme Q10 admitted to the intensive care unit.

Authors:  Mohammad Amin Valizade Hasanloei; Aidin Zeinaly; Mehran Rahimlou; Hadi Houshyar; Solma Moonesirad; Reza Hashemi
Journal:  J Nutr Sci       Date:  2021-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.